• VitalHub has announced that it has signed an agreement with Jayex Healthcare to purchase the assets of Jayex’s on-premise hospital queue management system
  • The purchase will be completed as £1.04 million in cash and £0.26 million in VitalHub common shares for a total consideration of £1.3 million
  • Jayex Healthcare is a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms
  • VitalHub develops technology solutions for health and human services providers
  • VitalHub (VHI) is steady, trading at $2.97 per share

VitalHub has announced that it has signed an agreement with Jayex Healthcare to purchase the assets of Jayex’s on-premise hospital queue management system.

The purchase will be completed as £1.04 million in cash and £0.26 million in VitalHub common shares for a total consideration of £1.3 million.

A total of 150,078 shares will be issued at C$2.915 per share. VitalHub currently has 36,146,564 common shares issued and outstanding.

In addition, Jayex may receive an earn-out based on earned revenues of the Jayex system for 24 months after closing of the acquisition, capped at a total of £1 million.

VitalHub CEO Dan Matlow commented,

“With this acquisition, VitalHub will now significantly increases its number of customers using at least one module of our patient journey solutions within the UK and Australia. This deal affords VitalHub the opportunity to introduce the Jayex customer base to our entire product portfolio”

Jayex Healthcare is a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms.

VitalHub plans to integrate the Jayex system into the company’s subsidiary Intouch with Health, which provides similar on-premise hospital queue management.

VitalHub is a Canada-based firm that develops technology solutions for health and human services providers in the mental health, long-term care, community health service, home health, social service, and acute care sectors.

VitalHub (VHI) is steady, trading at $2.97 per share as of 10:56 am ET. 

More From The Market Online

Independent tests of BlackBerry cyber defense scores solid results

A new study finds that BlackBerry’s (TSX:BB) endpoint protection platform blocked the most cyberattacks while using fewer system resources.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.

TELUS becomes one of the first Canadian organizations to offer GenAI

TELUS (TSX:T) becomes one of the first Canadian organizations to offer GenAI solutions to its customer base.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.